Home » Stocks » Biomerica

Biomerica, Inc. (BMRA)

Stock Price: $8.81 USD -0.06 (-0.68%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $8.84 +0.03 (0.34%) Aug 7, 7:52 PM

Stock Price Chart

Key Info

Market Cap 103.54M
Revenue (ttm) 5.13M
Net Income (ttm) -2.64M
Shares Out 11.75M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $8.81
Previous Close $8.87
Change ($) -0.06
Change (%) -0.68%
Day's Open 8.87
Day's Range 8.63 - 9.03
Day's Volume 257,386
52-Week Range 2.05 - 23.39

More Stats

Market Cap 103.54M
Enterprise Value 102.77M
Earnings Date (est) Aug 27, 2020
Ex-Dividend Date n/a
Shares Outstanding 11.75M
Float 9.26M
EPS (basic) -0.27
EPS (diluted) -0.27
FCF / Share -0.19
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 491,793
Short Ratio 0.56
Short % of Float 6.39%
Beta -0.71
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 20.17
PB Ratio 22.62
Revenue 5.13M
Operating Income -2.68M
Net Income -2.64M
Free Cash Flow -1.85M
Net Cash 767,374
Net Cash / Share 0.07
Gross Margin 25.17%
Operating Margin -52.19%
Profit Margin -51.40%
FCF Margin -35.94%
ROA -25.22%
ROE -61.09%
ROIC -55.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.25*
(16.35% upside)
Low
9.50
Current: $8.81
High
11.00
Target: 10.25
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue5.205.565.795.144.965.126.476.08
Revenue Growth-6.53%-3.93%12.68%3.58%-3.09%-20.89%6.44%-
Gross Profit1.291.752.021.521.541.672.432.30
Operating Income-2.41-1.48-0.95-0.83-0.67-0.450.510.50
Net Income-2.39-1.47-0.91-1.50-0.33-0.220.540.55
Shares Outstanding9.218.578.337.637.557.377.026.89
Earnings Per Share-0.26-0.17-0.11-0.20-0.04-0.030.070.08
EPS Growth-------12.5%-
Operating Cash Flow-2.24-1.17-0.72-0.21-0.41-0.861.390.15
Capital Expenditures-0.10-0.13-0.10-0.09-0.01-0.14-0.26-0.16
Free Cash Flow-2.35-1.30-0.82-0.30-0.41-1.001.14-0.02
Cash & Equivalents0.691.201.231.891.091.512.471.08
Total Debt-------0.04
Net Cash / Debt0.691.201.231.891.091.512.471.03
Assets5.255.225.025.736.126.476.395.57
Liabilities1.260.900.530.510.520.560.560.59
Book Value3.984.334.495.225.605.915.834.98
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Biomerica, Inc.
Country United States
Employees 54
CEO Zackary S. Irani

Stock Information

Ticker Symbol BMRA
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BMRA

Description

Biomerica, Inc., together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The company's diagnostic test kits are used to analyze blood, urine, or fecal samples from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the human body in extremely small concentrations. It primarily offers its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the point of care and clinical laboratories worldwide. The company is also developing InFoods, an irritable bowel syndrome (IBS) therapy technology and diagnostic-guided therapy, which is in clinical studies to identify specific foods that when removed from the patient's diet can alleviate the patient's IBS symptoms. Biomerica, Inc. was founded in 1971 and is headquartered in Irvine, California.